Medplus Health Services Limited (MEDPLUS) - Cash Flow Conversion Efficiency

Latest as of December 2023: 0.074x

Based on the latest financial reports, Medplus Health Services Limited (MEDPLUS) has a cash flow conversion efficiency ratio of 0.074x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.14 Billion ≈ $12.35 Million USD) by net assets (Rs15.46 Billion ≈ $167.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medplus Health Services Limited - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Medplus Health Services Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MEDPLUS total liabilities for a breakdown of total debt and financial obligations.

Medplus Health Services Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medplus Health Services Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sichuan Yimikang Environmental Tech Co Ltd
SHE:300249
0.051x
Hunan Keli Motor Co Ltd
SHE:002892
0.042x
Phibro Animal Health Corporation
NASDAQ:PAHC
0.058x
Jiangsu Gian Technology Co Ltd
SHE:300709
0.202x
Sixt SE
XETRA:SIX3
0.081x
Mader Group Ltd
AU:MAD
0.132x
Aevis Victoria SA
SW:AEVS
0.037x
Taiflex Scientific Co Ltd
TW:8039
0.090x

Annual Cash Flow Conversion Efficiency for Medplus Health Services Limited (2019–2025)

The table below shows the annual cash flow conversion efficiency of Medplus Health Services Limited from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see MEDPLUS company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs17.40 Billion
≈ $188.16 Million
Rs5.54 Billion
≈ $59.96 Million
0.319x +249.68%
2024-03-31 Rs15.77 Billion
≈ $170.59 Million
Rs1.44 Billion
≈ $15.54 Million
0.091x +50.23%
2023-03-31 Rs14.91 Billion
≈ $161.19 Million
Rs904.10 Million
≈ $9.78 Million
0.061x -49.40%
2022-03-31 Rs14.17 Billion
≈ $153.27 Million
Rs1.70 Billion
≈ $18.37 Million
0.120x +2931.44%
2021-03-31 Rs7.31 Billion
≈ $79.07 Million
Rs28.91 Million
≈ $312.65K
0.004x +131.75%
2020-03-31 Rs5.29 Billion
≈ $57.22 Million
Rs-65.89 Million
≈ $-712.58K
-0.012x -102.47%
2019-03-31 Rs2.91 Billion
≈ $31.51 Million
Rs1.47 Billion
≈ $15.86 Million
0.503x --

About Medplus Health Services Limited

NSE:MEDPLUS India Pharmaceutical Retailers
Market Cap
$1.13 Billion
Rs104.66 Billion INR
Market Cap Rank
#8584 Global
#408 in India
Share Price
Rs872.15
Change (1 day)
-0.96%
52-Week Range
Rs741.80 - Rs977.20
All Time High
Rs1290.00
About

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more